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Jan I-Shiow and colleagues found that hypoglycemia in
pneumococcal disease was associated with high mortality.1 The
authors listed increased glucose utilization and depressed
gluconeogenesis as causes, without elaborating on the etiology
of these phenomena. It is not clear from the investigation how
these abnormalities of glucose processing are linked to increased
mortality.
Gluconeogenesis, like cardiovascular function and pulmonary
edema clearance, is dependent on beta-receptor stimulation.2,3 In
septicemia, previous investigations found a lack of a cardiovascular
response to beta-agonists.
This hypo-responsiveness to beta-agonists has been investigat-
ed in a rabbit model of Escherichia coli lipopolysaccharide (LPS)-
induced endotoxaemia.4 The authors found a signiﬁcant reduction
of expression of G-proteins, which transmit the effects of beta-
receptors and therefore inotropes intracellularly by activation of
the adenylate cyclase. Subsequent studies of human blood
mononuclear cells exposed to serum from septic patients showed
that beta-receptor-mediated accumulation of intracellular cyclic
adenosine monophosphate (cAMP) was reduced, and this effect
was more pronounced in patients in shock.5,6 The authors found
that a hyperactivation of inhibitory G-proteins reduced the activity
of adenylate cyclase on stimulation by beta-agonists. Tumor
necrosis factor (TNF) was identiﬁed as a potential cause of this
disruption of the G-protein function within the beta-adrenergic
pathway.7 TNF also triggers the release of nitric oxide which,
through activation of cytosolic mediators (Bcl-2, Bcl-xL), leads to
disruption of mitochondrial function with release of proteins
including cytochrome c from mitochondria.8 Reduced mitochon-
drial function leads to reduced oxidative phosphorylation, and
energy has to be generated through glycolysis resulting in
increased glucose consumption to meet adenosine triphosphate
(ATP) demands. The reduction of glucose levels is particularly
accentuated in pneumococcal disease and has previously been
described for the cerebrospinal ﬂuid of patients with pneumococ-
cal meningitis-related hearing loss.9 This is because of additional
disruption of mitochondrial function by pneumolysin, a cytotoxic
virulence factor of Streptococcus pneumoniae.10 Reduced glucose
levels are therefore linked to increased mortality because they1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.03.007reﬂect in addition to a reduced response of tissues with glucose
mobilization also a reduced response of the cardiovascular system
to endogenous and exogenous beta-agonists, as well as a
disruption of mitochondrial function with subsequent cell death.
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